FDA Approved: ETRAVIRINE — Supplemental Application (Patriot Pharmaceuticals)

View source ↗

Summary

The FDA approved a supplemental application for etravirine (ETRAVIRINE) submitted by Patriot Pharmaceuticals. The action pertains to an HIV-1 treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• etravirine (etravirine)

Snippet

SUPPL AP for ETRAVIRINE (ETRAVIRINE)